SCHEMBL25003134

SCHEMBL25003134

CCCCOc1ccc(-c2nccc(C(=O)NN)n2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 5/20 0.51
▸ RAB9A P51151 5/20 0.51
▸ SMN1; SMN2 Q16637 5/20 0.51
▸ KDM4E B2RXH2 2/20 0.51
▸ ALDH1A1 P00352 2/20 0.51
▸ LMNA P02545 4/20 0.50
▸ HSD17B10 Q99714 4/20 0.50
▸ MEN1 O00255 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ STAT3 P40763 1/20 0.48
▸ SMPD1 P17405 1/20 0.47
▸ RARB P10826 4/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ GAA P10253 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ MAPT P10636 2/20 0.44
▸ HPGD P15428 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25003794 0.95 PLK1 (0.49) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL25003126 0.90 ALDH1A1 (0.51) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL25002892 0.86 NPC1 (0.52) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL25003826 0.85 CA1 (0.54) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL25003142 0.82 ALDH1A1 (0.53) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL25002912 0.81 PLA2G2A (0.48) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL25003824 0.80 CYP1A2 (0.51) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL25003153 0.80 KMT2A (0.48) NPC1RAB9ASMN1; SMN2KDM4EMEN1
SCHEMBL25003131 0.78 MAP4K4 (0.55) RAB9ASMN1; SMN2KDM4EALDH1A1LMNA
SCHEMBL7323928 0.78 RARB (0.63) NPC1RAB9ASMN1; SMN2LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023010192-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS EUROFARMA LABORATÓRIOS S.A. (BR) 2023-02-09 — — WO disclosed
Send feedback